However, these results still provide some novel insights into understanding the role that GPR30 plays in the estrogenic action on the pathology of AD and they also indicate this receptor may represent one preventing and therapeutic target against hippocampus‐based, estrogen‐related learning and memory impairments. The gene discussed is GPER1; the disease is memory impairment.